Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - medroxyprogesterone acetate 2.5mg;   - tablet - 2.5 mg - active: medroxyprogesterone acetate 2.5mg   excipient: calcium stearate lactose monohydrate liquid paraffin maize starch purified talc purified water sucrose sunset yellow fcf - provera low dosage (2.5mg, 5mg and 10mg tablets) are indicated for: · diagnosis of primary and secondary amenorrhoea · treatment of dysfunctional (anovulatory) uterine bleeding · opposition of endometrial effects of estrogen in menopausal women being treated with estrogen (hormone replacement therapy [hrt]) · treatment of endometriosis.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - medroxyprogesterone acetate 5mg;   - tablet - 5 mg - active: medroxyprogesterone acetate 5mg   excipient: calcium stearate indigo carmine lactose monohydrate liquid paraffin maize starch purified talc purified water sucrose - provera low dosage (2.5mg, 5mg and 10mg tablets) are indicated for: · diagnosis of primary and secondary amenorrhoea · treatment of dysfunctional (anovulatory) uterine bleeding · opposition of endometrial effects of estrogen in menopausal women being treated with estrogen (hormone replacement therapy [hrt]) · treatment of endometriosis.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - medroxyprogesterone acetate 100mg;   - tablet - 100 mg - active: medroxyprogesterone acetate 100mg   excipient: docusate sodium gelatin hydrolysate isopropyl alcohol macrogol 400 magnesium stearate maize starch microcrystalline cellulose purified water sodium benzoate sodium starch glycolate - provera 100mg and 200mg tablets are indicated as adjunctive and/or palliative treatment of recurrent and/or metastatic endometrial or renal carcinoma and, in the treatment of hormonally-dependent, recurrent breast cancer in post-menopausal women.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - medroxyprogesterone acetate 200mg;   - tablet - 200 mg - active: medroxyprogesterone acetate 200mg   excipient: docusate sodium gelatin hydrolysate isopropyl alcohol macrogol 400 magnesium stearate maize starch microcrystalline cellulose purified water sodium benzoate sodium starch glycolate - provera 100mg and 200mg tablets are indicated as adjunctive and/or palliative treatment of recurrent and/or metastatic endometrial or renal carcinoma and, in the treatment of hormonally-dependent, recurrent breast cancer in post-menopausal women.

Irland - Englisch - HPRA (Health Products Regulatory Authority)

upjohn eesv - amlodipine - tablet - 10 milligram(s) - dihydropyridine derivatives; amlodipine

Irland - Englisch - HPRA (Health Products Regulatory Authority)

upjohn eesv - amlodipine - tablet - 5 milligram(s) - dihydropyridine derivatives; amlodipine

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - colestipol hydrochloride 5 g - granules for oral suspension - 5 g - active: colestipol hydrochloride 5 g - colestid is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol and low-density lipoprotein (ldl) cholesterol in patients with primary hypercholesterolaemia (elevated low density lipoproteins (ldl) cholesterol) who do not respond adequately to diet and to reduce the risks of atherosclerotic coronary artery disease and myocardial infarction. it may be used as the sole agent or in combination with additional lipid lowering agents. when compared to conventional measures, intensive lipid-lowering combination therapy, which included colestid plus either niacin or lovastatin, significantly reduced the frequency of progression and increased the frequency of regression of coronary atherosclerotic lesions in patients with, or at risk for, symptomatic coronary artery disease

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methylprednisolone acetate 40 mg/ml - injection (depot) - 40 mg/ml - active: methylprednisolone acetate 40 mg/ml excipient: hydrochloric acid macrogol 3350 miripirium chloride sodium chloride sodium hydroxide water for injection - primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy; mineralocorticoid supplementation is of particular importance). acute adrenocortical insufficiency (hydrocortisone or cortisone is the drug of choice; mineralocorticoid supplementation may be necessary, particularly when synthetic analogs are used). congenital adrenal hyperplasia. hypercalcemia associated with cancer. nonsuppurative thyroiditis.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - testosterone cipionate 100 mg/ml (101mg with manucturers overage.) - solution for injection - 100 mg/ml - active: testosterone cipionate 100 mg/ml (101mg with manucturers overage.) excipient: benzyl alcohol benzyl benzoate cottonseed oil - depo-testosterone sterile solution is indicated for replacement therapy in males in conditions associated with symptoms of deficiency or absence of endogenous testosterone.

Neuseeland - Englisch - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - methylprednisolone 100mg - tablet - 100 mg - active: methylprednisolone 100mg - primary or secondary adrenocortical insufficiency (hydrocortisone or cortisone is the first choice; synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance). · congenital adrenal hyperplasia. · nonsuppurative thyroiditis · hypercalcemia associated with cancer